Chase AIPricingFAQs
Display currency
Loading news…

Ology Bioservices

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Alachua, Florida, United States Founded 1999 251-500 employees For Profit

Ology Bio is a biologics CDMO specializing in single use processes up to BSL-3

Ology Bioservices was acquired by Resilience in 2021.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
58
Patents
4
12 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active products
16
Patents granted
4
Trademarks
12
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
1999
Employees
251-500
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
5
HQ
Alachua, Florida, United States
Region
East Coast, Southern US
Exit date
Apr 12, 2021

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.5
Trend (90d)
-0.3

Key People at Ology Bioservices

Chief Scientific Officer
58
professional contacts at Ology Bioservices
Contact execs at Ology Bioservices

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Ology Bioservices

Loading news…

FAQs about Ology Bioservices

People who checked this page also checked these

Browse the full Acquirezy directory.
Ology Bioservices - Company Profile, Full Acquisitions List, Funding and Investments